Key statistics
As of last trade, Perspective Therapeutics Inc (CATX:ASQ) traded at 3.38, 48.25% above the 52 week low of 2.28 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.06 |
---|---|
High | 3.42 |
Low | 2.94 |
Bid | 3.37 |
Offer | 3.39 |
Previous close | 3.00 |
Average volume | 2.55m |
---|---|
Shares outstanding | 67.43m |
Free float | 53.52m |
P/E (TTM) | -- |
Market cap | 202.28m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:06 GMT.
More ▼
- Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
- Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
- Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
- Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
- Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
- Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research
- Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day
- Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine
More ▼